Newbridge

NewBridge Pharmaceuticals is a specialty pharmaceutical company based in Dubai, United Arab Emirates, established in 2010. The company focuses on in-licensing and commercializing innovative therapeutics developed by global pharmaceutical and biotechnology companies, specifically targeting the Middle East and North Africa (MENA) region. Their mission is to bridge the access gap by introducing FDA or EMA-approved products to address unmet medical needs in the region .

Therapeutic Areas of Focus

NewBridge Pharmaceuticals specializes in several key therapeutic areas:

• Oncology: Cancer treatments, including targeted therapies.
• Immunology: Immunological disorders and autoimmune diseases.
• Neuroscience: Neurological conditions and disorders.NSHCS
• Gastrointestinal Diseases: Digestive system disorders.
• Rare Diseases: Treatment for rare and complex conditions .